網膜疾患治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2827)
◆英語タイトル:Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2827
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:98
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、網膜疾患治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症)、用途別市場規模(病院薬局、小売薬局、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・網膜疾患治療薬の市場動向
・企業の競争状況、市場シェア
・網膜疾患治療薬の種類別市場規模(黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症)
・網膜疾患治療薬の用途別市場規模(病院薬局、小売薬局、その他)
・網膜疾患治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・網膜疾患治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・網膜疾患治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・網膜疾患治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・網膜疾患治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Merck、Novartis、Allergan、Roche、Regeneron、Santen)
・結論
【レポートの概要】

Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.

Market Analysis and Insights: Global Retinal Disease Therapeutics Market
The global Retinal Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Disease Therapeutics market.

Global Retinal Disease Therapeutics Scope and Market Size
Retinal Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Allergan
Roche
Regeneron
Santen

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Macular Degeneration
1.2.3 Diabetic Macular Edema
1.2.4 Diabetic Retinopathy
1.2.5 Retinal Vein Occlusion
1.3 Market by Application
1.3.1 Global Retinal Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinal Disease Therapeutics Market Perspective (2016-2027)
2.2 Retinal Disease Therapeutics Growth Trends by Regions
2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Disease Therapeutics Industry Dynamic
2.3.1 Retinal Disease Therapeutics Market Trends
2.3.2 Retinal Disease Therapeutics Market Drivers
2.3.3 Retinal Disease Therapeutics Market Challenges
2.3.4 Retinal Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinal Disease Therapeutics Players by Revenue
3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue
3.4 Global Retinal Disease Therapeutics Market Concentration Ratio
3.4.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2020
3.5 Retinal Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Retinal Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Retinal Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Disease Therapeutics Breakdown Data by Type
4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Retinal Disease Therapeutics Breakdown Data by Application
5.1 Global Retinal Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinal Disease Therapeutics Market Size (2016-2027)
6.2 North America Retinal Disease Therapeutics Market Size by Type
6.2.1 North America Retinal Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Retinal Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Retinal Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Retinal Disease Therapeutics Market Size by Application
6.3.1 North America Retinal Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Retinal Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Retinal Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Retinal Disease Therapeutics Market Size by Country
6.4.1 North America Retinal Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Retinal Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinal Disease Therapeutics Market Size (2016-2027)
7.2 Europe Retinal Disease Therapeutics Market Size by Type
7.2.1 Europe Retinal Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Retinal Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Retinal Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Retinal Disease Therapeutics Market Size by Application
7.3.1 Europe Retinal Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Retinal Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Retinal Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Retinal Disease Therapeutics Market Size by Country
7.4.1 Europe Retinal Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Retinal Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinal Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Retinal Disease Therapeutics Market Size by Type
9.2.1 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Retinal Disease Therapeutics Market Size by Application
9.3.1 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Retinal Disease Therapeutics Market Size by Country
9.4.1 Latin America Retinal Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinal Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Retinal Disease Therapeutics Introduction
11.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Retinal Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Retinal Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Retinal Disease Therapeutics Introduction
11.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Regeneron
11.5.1 Regeneron Company Details
11.5.2 Regeneron Business Overview
11.5.3 Regeneron Retinal Disease Therapeutics Introduction
11.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.5.5 Regeneron Recent Development
11.6 Santen
11.6.1 Santen Company Details
11.6.2 Santen Business Overview
11.6.3 Santen Retinal Disease Therapeutics Introduction
11.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.6.5 Santen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 網膜疾患治療薬の世界市場規模・現状・予測2021年-2027年(Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。